Squarepoint’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-133,885
Closed -$669K 2709
2025
Q1
$669K Buy
133,885
+119,179
+810% +$596K ﹤0.01% 1734
2024
Q4
$106K Sell
14,706
-46,982
-76% -$339K ﹤0.01% 2528
2024
Q3
$379K Buy
+61,688
New +$379K ﹤0.01% 1901
2024
Q2
Sell
-13,178
Closed -$134K 2458
2024
Q1
$134K Sell
13,178
-99,595
-88% -$1.01M ﹤0.01% 2195
2023
Q4
$1.27M Buy
+112,773
New +$1.27M ﹤0.01% 1246
2023
Q3
Sell
-139,911
Closed -$494K 2432
2023
Q2
$494K Sell
139,911
-74,353
-35% -$262K ﹤0.01% 1602
2023
Q1
$904K Buy
+214,264
New +$904K ﹤0.01% 1216
2022
Q3
Sell
-28,133
Closed -$329K 2048
2022
Q2
$329K Sell
28,133
-66,494
-70% -$778K ﹤0.01% 1546
2022
Q1
$576K Buy
94,627
+80,246
+558% +$488K ﹤0.01% 1426
2021
Q4
$132K Sell
14,381
-46,227
-76% -$424K ﹤0.01% 2238
2021
Q3
$685K Buy
60,608
+50,256
+485% +$568K ﹤0.01% 1239
2021
Q2
$102K Buy
+10,352
New +$102K ﹤0.01% 2408
2020
Q4
Sell
-20,427
Closed -$270K 2492
2020
Q3
$270K Buy
+20,427
New +$270K ﹤0.01% 1747
2019
Q4
Sell
-11,248
Closed -$22K 2361
2019
Q3
$22K Sell
11,248
-10,272
-48% -$20.1K ﹤0.01% 2166
2019
Q2
$51K Sell
21,520
-12,346
-36% -$29.3K ﹤0.01% 2206
2019
Q1
$98K Buy
+33,866
New +$98K ﹤0.01% 1988
2017
Q4
Sell
-710
Closed -$49K 2050
2017
Q3
$49K Buy
+710
New +$49K ﹤0.01% 1545
2017
Q1
Sell
-371
Closed -$362K 1491
2016
Q4
$362K Buy
371
+329
+783% +$321K 0.01% 1029
2016
Q3
$37K Buy
+42
New +$37K ﹤0.01% 976